You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable Early-stage (IA to IIIB)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Early-stage Non-small Cell Lung Cancer

Completed
  • Non-small Cell Lung Cancer
    • Alexandria, Egypt
    • +3 more
    Nov 21, 2022

    NSCLC Trial (Durvalumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jun 22, 2023

    Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Aug 6, 2023

      Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)

      Not yet recruiting
      • Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
      • (no location specified)
      Aug 10, 2022

      Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

      Recruiting
      • Melanoma Stage III
      • Melanoma Stage IV
      • Amsterdam, NH, Netherlands
        Antoni van Leeuwenhoek ziekenhuis
      Feb 11, 2022

      Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

      Not yet recruiting
      • Early Breast Cancer
      • (no location specified)
      Apr 12, 2023

      NSCLC Trial (Dupilumab, Cemiplimab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Dupilumab
      • Cemiplimab
      • (no location specified)
      Oct 12, 2023

      Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

      Terminated
      Has Results
      • Resectable Lung Non-Small Cell Carcinoma
      • +10 more
      • Bintrafusp Alfa
      • Therapeutic Conventional Surgery
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 27, 2022

      Melanoma Trial in Salt Lake City (Nivolumab, HF10)

      Terminated
      Has Results
      • Melanoma
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Jun 9, 2022

      Non Small Cell Lung Cancer Trial in Changsha (Atezolizumab)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      May 19, 2022

      NSCLC Trial in Xi'an (Furmonertinib+cisplating/pemetrexed)

      Recruiting
      • Non-small Cell Lung Cancer
      • Xi'an, Shannxi, China
        Tangdu Hospital
      Jun 20, 2022

      Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

      Not yet recruiting
      • Non Squamous Non Small Cell Lung Cancer
      • EGFR Positive Non-small Cell Lung Cancer
      • Toripalimab plus Chemotherapy
      • (no location specified)
      Jul 28, 2023

      Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

      Not yet recruiting
      • Stage II-IIIB(N2) Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 26, 2023

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

      Recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +21 more
      • Transcutaneous Electrical Nerve Stimulation
      • Atlanta, Georgia
      • +2 more
      Nov 21, 2022

      Stage IA Lung Cancer Trial in Shanghai (The disposable pulmonary radiofrequency ablation catheter and pulmonary radiofrequency

      Not yet recruiting
      • Stage IA Lung Cancer
      • The disposable pulmonary radiofrequency ablation catheter and pulmonary radiofrequency ablation system
      • The disposable percutaneous radiofrequency ablation needle and pulmonary radiofrequency ablation system
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Sep 18, 2023

      Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

      Recruiting
      • Lung Cancer
      • AMG 510
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 10, 2022

      Neoadjuvent, PD-1 Inhibitor, Lung Cancer Trial in Xi'an (neoadjuvant PD-1 inhibitor, anlotinib combined with chemo)

      Recruiting
      • Neoadjuvent
      • +4 more
      • neoadjuvant PD-1 inhibitor, anlotinib combined with chemotherapy
      • Xi'an, China
        Tangdu Hospital, the Air Force Military University
      May 26, 2022

      Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

      Recruiting
      • Non Small Cell Lung Cancer
      • anti-PD-1 or anti-PD-L1
      • +2 more
      • Shanghai, China
        Oncology Department, Shanghai Chest Hospital
      Jul 26, 2022

      Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,

      Not yet recruiting
      • Lung Non-Small Cell Carcinoma
      • +8 more
      • Best Practice
      • +2 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Dec 29, 2022

      NSCLC Trial in Philadelphia (device, drug, other)

      Not yet recruiting
      • NSCLC
      • Aliya Pulsed Electric Fields (PEF) ablation
      • +3 more
      • Philadelphia, Pennsylvania
        Temple University
      Oct 24, 2022

      Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma

      Active, not recruiting
      • Resectable Soft Tissue Sarcoma
      • +7 more
      • Hypofractionated Radiation Therapy
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 22, 2022

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

      Recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +20 more
      • Best Practice
      • +2 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jan 5, 2023

      Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

      Recruiting
      • Borderline Resectable Pancreatic Adenocarcinoma
      • +5 more
      • Durvalumab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

      Recruiting
      • Leiomyosarcoma
      • +29 more
      • Definitive Surgical Resection
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Apr 26, 2022

      Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

      Recruiting
      • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
      • +2 more
      • Ipilimumab
      • +3 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Feb 11, 2022